Victoria's Secret Defends Leadership & Strategy Amidst Proxy Battle, Citing 141% TSR
VSCO has more than doubled off its 52-week low of $17.53.
Summary
Victoria's Secret & Co. issued a letter to shareholders defending its current leadership and 'Path to Potential' strategy against an activist proxy contest, highlighting a 141% total shareholder return since August 2024 and strong fiscal 2025 results.
Key Events · Corporate Governance and Compliance · VSCO
-
Proxy Contest Defense
Victoria's Secret & Co. issued a letter to shareholders defending its current Board and CEO Hillary Super against an activist proxy contest launched by BBRC International.
-
Strong Performance Highlighted
The company cited a 141% Total Shareholder Return (TSR) since CEO Hillary Super's appointment in August 2024, outperforming peer groups and market indices.
-
Fiscal 2025 Results Cited
VS&Co reported accelerated comparable sales growth of 5% and a 15% increase in adjusted net income for fiscal year 2025 as evidence of successful strategy execution.
-
Shareholder Vote Urged
The Board encouraged shareholders to vote 'FOR' all of its highly qualified director nominees at the upcoming Annual Meeting on Thursday, June 11, 2026.
Analysis · VSCO · Trade & Services
Victoria's Secret & Co. is actively campaigning to retain its current board and management in the face of a proxy contest initiated by its second-largest shareholder, BBRC International. This filing provides the company's detailed defense, highlighting strong financial and operational performance, including significant shareholder returns and growth metrics. The outcome of the Annual Meeting on June 11, 2026, will determine the company's strategic direction and leadership, making this a critical communication in the ongoing battle for control.
At the time of this filing, VSCO was trading at $44.83 on NYSE in the Trade & Services sector, with a market capitalization of approximately $3.6B. The 52-week trading range was $17.53 to $66.89. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.